Our data suggest that caspase-2 catalytic activity is partly required for its function in fat metabolism, with Casp2C320S mice having reduced fat accumulation in adipose tissue (both gWAT and dWAT) and reduced age-related liver steatosis incidence at 12 months. The gene discussed is CASP2; the disease is fatty liver disease.